Physician profile
Luis Vaca
NPI 1407055114
$8,338.39
in general payments reported to CMS, 2019-2025
9 companies · $1,058 in 2025
The $1,058 reported for 2025 was more than what a typical Neuroradiology provider received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,178 · 2020: $1,808 · 2021: $1,189 · 2022: $779 · 2023: $433 · 2024: $895 · 2025: $1,058.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,384.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,539.14 | 2019-2025 | Penumbra System, Red 72, Pod |
| Imperative Care, INC | $1,571.07 | 2024-2025 | Symphony Catheter, Zoom Reperfusion Catheter, Truvic Generator |
| Stryker Corporation | $1,127.46 | 2019-2023 | Axs Vecta 71 |
| Balt USA, LLC | $589.32 | 2020-2022 | |
| Microvention, INC. | $225.96 | 2020 | |
| Inari Medical, INC. | $194.58 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Route 92 Medical, INC. | $38.46 | 2025 | |
| Medtronic USA, INC. | $28.97 | 2019 | |
| Medtronic, INC. | $23.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Vaca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.